Article
Potential Druggability of Mesenchymal Stem/Stromal Cell-derived Exosomes
25 Mar 2024
Abstract excerpt
Exosomes secreted by mesenchymal stem/stromal cells (MSC-Exos) are advantageous candidate sources for novel acellular therapy. Despite the current standards of good manufacturing practice (GMP), the deficiency of suitable quality-control methods and the difficulties in large-scale preparation largely restrict the development of therapeutic products and their clinical applications worldwide. Herein, we mainly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
